Amid growing concerns about the long-term health of the U.S. consumer, many investors have been seeking out companies with international exposure. For market...
Biotech stocks began the year with gusto, but sold off when the broader-market rally fizzled in February, as investors sought safer havens. Yet, with...
Stocks edged higher this morning amid easing concerns about the debt ceiling as negotiations in Washington gained steam. According to Oppenheimer’s John Stoltzfus, investors...